Mineralys Therapeutics Inc (OQ:MLYS)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for MLYS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 13/24 Mar 12/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -6,348  
Mar 13/24 Mar 12/24 Rodman David Malcom Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,348 $1.08
Mar 13/24 Mar 11/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -5,017  
Mar 13/24 Mar 11/24 Rodman David Malcom Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,017 $0.540
Feb 15/24 Feb 13/24 Rodman David Malcom Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 15/24 Feb 13/24 Levy Adam Scott Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 15/24 Feb 13/24 Congleton Jon Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 425,000  
Feb 13/24 Feb 12/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -6,349  
Feb 13/24 Feb 12/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -5,017  
Feb 13/24 Feb 12/24 Rodman David Malcom Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,349 $1.08
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for MLYS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 29th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 13/24 Mar 12/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -6,348  
Mar 13/24 Mar 11/24 Rodman David Malcom Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -5,017  
Mar 13/24 Mar 12/24 Rodman David Malcom Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,348 $1.08
Mar 13/24 Mar 11/24 Rodman David Malcom Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,017 $0.540
Feb 15/24 Feb 13/24 Rodman David Malcom Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 15/24 Feb 13/24 Levy Adam Scott Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 200,000  
Feb 15/24 Feb 13/24 Congleton Jon Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) 425,000  
Feb 14/24 Feb 12/24 Akkaraju Srinivas Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 555,555 $13.50
Feb 14/24 Feb 12/24 Samsara BioCapital GP, LLC Indirect Ownership Common Stock P - Open market or private purchase 555,555 $13.50
Feb 14/24 Feb 12/24 Ra Capital Management, L.P. Indirect Ownership Pre-Funded Warrants (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 549,755 $13.50
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $MLYS

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.